Literature DB >> 14683548

Open-door cervical expansile laminoplasty.

Michael Y Wang1, Barth A Green.   

Abstract

Cervical laminoplasty is becoming a popular technique for the treatment of cervical myelopathy that is the result of multilevel canal stenosis. Many variations in this technique, which was originally created in Japan, have been developed, all with the goal of increasing canal space and reconstructing the posterior bony arch. We describe our extensive experience with this procedure for the treatment of cervical spondylotic myelopathy.

Entities:  

Mesh:

Year:  2004        PMID: 14683548     DOI: 10.1227/01.neu.0000097513.91248.26

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  5 in total

1.  Open Door Laminoplasty: Creation Of A New Vertebral Arch.

Authors:  Monica Lara-Almunia; Javier Hernandez-Vicente
Journal:  Int J Spine Surg       Date:  2017-02-09

2.  Preservation of C7 spinous process does not influence the long-term outcome after laminoplasty for cervical spondylotic myelopathy.

Authors:  K Higashino; S Katoh; K Sairyo; T Sakai; H Kosaka; N Yasui
Journal:  Int Orthop       Date:  2006-06-01       Impact factor: 3.075

3.  Open-door cervical laminoplasty with preservation of posterior structures.

Authors:  Kalil G Abdullah; Takayuki Yamashita; Michael P Steinmetz; Daniel Lubelski; Jeffrey C Wang; Edward C Benzel; Thomas E Mroz
Journal:  Global Spine J       Date:  2012-03

4.  Effects of propofol or sevoflurane anesthesia induction on hemodynamics in patients undergoing fiberoptic intubation for cervical spine surgery: A randomized, controlled, clinical trial.

Authors:  Chiara Robba; Ega Qeva; Beatrice Borsellino; Simone Aloisio; Giulia Tosti; Federico Bilotta
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2017 Apr-Jun

5.  The Midterm Surgical Outcome of Modified Expansive Open-Door Laminoplasty.

Authors:  Kuang-Ting Yeh; Ru-Ping Lee; Ing-Ho Chen; Tzai-Chiu Yu; Cheng-Huan Peng; Kuan-Lin Liu; Jen-Hung Wang; Wen-Tien Wu
Journal:  Biomed Res Int       Date:  2016-08-03       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.